In patients with fibrosis ( N = 306), the overall T2DM incidence was 7.52%, with a higher rate in the IFN-based group (11.22%) than in the DAA-based group (5.77%), but this difference did not reach statistical significance (IRR 2.22, 95% CI, 0.73–7.10; p = 0.19).
← all excerpts
Long-Term Risk Trajectories of Diabetes Differ After Direct-Acting Antiviral and Interferon Therapy in Chronic Hepatitis C: A Real-World Cohort Study
1
0.1900
0.1900